MEMBER OF BIOQUÉBEC
Stem Cells: Regeneration Methods for the Visual System
STEMAXON is a Canadian biotechnology company located in Montréal which specializes in stem cell technology.
Restoring vision with stem cells
STEMAXON's cumulative IP, starting with the only proven human sporadic AD model (PCT) and AD-cascade related compounds (PCT) greatly advance drug development and testing in the treatment and early stage diagnostics of Alzheimer’ disease.
STEMAXON's Legal partners are Fasken Martineau.
STEMAXON has been nominated as a finalist for the ADRIQ's ''26th INNOVATION AWARD''
La biología y el tratamiento de la ceguera con células madre
Des cellulles souches pour soigner la vision
STEMAXON to validate the technology of iPSC differentiation into photoreceptor cells for cell therapy applications
El trasplante de fotorreceptores llega para curar la degeneración macular
Stem Cell Advance Brings Vision Repair in Sight
FOR ALL THE LATEST NEWS, PLEASE VISIT OUR LINKEDIN PAGE
In the News:
The Biology of Treating Blindness with Stem Cells
FOLLOW US ON LINKEDIN